Biocon

Mylan, Biocon help market generic insulin drugs

Mylan, Biocon help market generic insulin drugs

Yahoo/AP

Biocon, Bristol-Myers in deal for oral insulin drug

Biocon, Bristol-Myers in deal for oral insulin drug

Reuters

Abbott, Biocon to develop nutrition products for India

Abbott, Biocon to develop nutrition products for India

Reuters

Pfizer's $200 Million Mistake

Pfizer's $200 Million Mistake

Motley Fool

Novo Advances as Pfizer Drops Diabetes Deal

Novo Advances as Pfizer Drops Diabetes Deal

Bloomberg

Biocon Plunges After Ending Pfizer Insulin Distribution Pact

Biocon Plunges After Ending Pfizer Insulin Distribution Pact

Bloomberg

Biocon Rises After Starting Manufacture of Lipitor Ingredients

Biocon Rises After Starting Manufacture of Lipitor Ingredients

Bloomberg

Can Biocon get a $1B pharma deal for its oral insulin program?

Can Biocon get a $1B pharma deal for its oral insulin program?

Fierce Biotech

Bristol-Myers Squibb, Sanofi-Aventis in race for drug marketing pact with Biocon

Bristol-Myers Squibb, Sanofi-Aventis in race for drug marketing pact with Biocon

Economic Times, India

News

Biocon Says Revenue From Pfizer Deal to Begin in Fiscal 2012

Bloomberg